Business Wire

BOMBERG

15.7.2021 11:14:08 CEST | Business Wire | Press release

Share
BOMBERG Announces World Premiere "BB01 Automatic Cure the BullDog"

True to its rebellious spirit, BOMBERG has launched the first watch ever to incorporate CBD leaves extract: "BB01 Automatic Cure the BullDog ".

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210715005041/en/

BOMBERG connections to CBD are rooted in the relationship nurtured over the years with dogs.

Since the BOMBERG launch in 2012 the bulldogs, Bolt in Mexico and Duke & Paulina in Switzerland, have always been the official brand ambassadors and mascot.

In 2015 BOMBERG partnered with “Barry Foundation ”, the world’s oldest breeder of St. Bernards and in 2020 with the campaign “Take care of me” supported the “Black Jaguar-White Tiger Foundation ”.

After Bolt suffered an episode of stress, BOMBERG got in touch with “Bouledogue Attitude Foundation ”, in Switzerland, that recommended CBD-based food for its natural properties that help relieve anxiety as well as create a stronger nervous system.

Bolt recovered quickly and helps now spreading the word about BB-01 Automatic Cure the BullDog , the world’s first watch ever containing 100% natural CBD with 0% THC.

Treading an unbeaten path away from the roots of traditional lifestyle industry, BOMBERG embraces the free and insurgent spirit of millions of people around the world who dare to be different and to create their own maverick rules.

The new BB01 Automatic Cure the BullDog combines BOMBERG revolutionary, free and adventurous soul with an outstanding concept and a phenomenal design.

The dial features the instantly recognisable CBD indica plant with its seven serrated leaves and a powerful Super-LumiNova that makes the watch always readable.

BB01 Automatic Cure the BullDog presents real CBD indica leaves extract inside the dial and a strap made of authentic hemp, produced by our partner in the United States, following the strictest sustainability and natural production standards.

BB-01 Automatic Cure the BullDog is the ultimate symbol of audacity signed by BOMBERG .

Technical details:

Reference:

CT43ASS.30-1.11

Movement:

Automatic 3 hands, Sellita SW200, 38 hours power reserve

Case:

43mm, stainless steel case

 

Outer ring with CBD leaves pattern

Dial:

Strong Superluminova on the Indica leaf

 

Real organic US hemp inside the dial below the Indica leaf

Crystal:

Sapphire with anti reflective coating

WR:

50m

Strap:

Fabric strap made with US hemp

Buckle:

Stainless steel folding clasp

 

RRP CHF, VAT excl. CHF 1’790

 

Quantity SPECIAL EDITION with limited production

Link:

ClickThru

Social Media:

https://www.facebook.com/bombergofficial

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

FPT Named an OpenAI Select Partner6.8.2026 02:00:00 CEST | Press release

Global IT corporation FPT today announced that it has been named an OpenAI Select Partner within the OpenAI Partner Network. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260805503787/en/ FPT Named an OpenAI Select Partner The OpenAI Partner Network is a global program for partners to build, sell, and deliver AI solutions with OpenAI. It brings together partners with deep industry expertise, delivery capabilities, and customer relationships while equipping them with resources, enablement, and support to help enterprises adopt OpenAI frontier models and products and turn them into measurable impact. As an OpenAI Select Partner, FPT will continue working with OpenAI to help organizations build, deploy, and scale AI solutions responsibly and effectively. This work will help organizations get more useful work from every token and stronger performance per dollar with GPT‑5.6, while using ChatGPT Work to turn ambitious goals into

U.S. FDA Approves Takeda’s ORZEYFUL™ (oveporexton), the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 16.8.2026 00:10:00 CEST | Press release

Adults Taking ORZEYFUL Experienced Significant and Meaningful Improvements Across the Full Range of Symptoms of Narcolepsy Type 1 (NT1) in Clinical Trials Compared to Those on Placebo As a First-in-Class Orexin Treatment, ORZEYFUL has the Potential to Redefine NT1 Care Beyond Individual Symptoms Takeda is Advancing U.S. Launch Preparations and Expects to Make ORZEYFUL Available Following Completion of the Drug Enforcement Administration (DEA) Scheduling Process Takeda (TSE:4502/NYSE:TAK) announced that the U.S. Food and Drug Administration (FDA) approved ORZEYFUL™ (oveporexton), an oral orexin receptor 2 (OX2R) agonist, for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults.* The persistent 24-hour nature of NT1 is driven by orexin deficiency and can severely impact people’s lives. As a first-in-class orexin treatment, ORZEYFUL is the only medicine indicated in the U.S. to treat the disease holistically rather than individual symptoms. “The FDA approval of OR

Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)5.8.2026 22:30:00 CEST | Press release

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to fourteen newly hired non-executive employees. The equity awards were granted on August 3, 2026 and consisted of options to purchase an aggregate of 139,355 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 66,300 shares. The options have an exercise price per share equal to $11.25, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restricted

Clinilabs Announces Medical Leadership Appointments5.8.2026 16:05:00 CEST | Press release

Bob Dagher, M.D., Named Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., Named Principal Investigator Clinilabs (“Clinilabs LLC”), a global, full-service contract research organization (CRO) specializing in central nervous system (CNS) drug and device development, today announced the appointments of Bob Dagher, M.D., as Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., as Principal Investigator of the Company’s Eatontown, New Jersey Clinical Research Unit (CRU). Dr. Dagher will provide strategic and medical leadership across the organization, while Dr. Siddiqui will lead the execution of research projects at the Company’s CRU. Together, they will support the design, development, and execution of clinical programs for pharmaceutical, biotechnology, and medical device sponsors advancing innovative therapies for psychiatric, neurological, substance use, and rare CNS disorders. “Clinilabs has earned the trust of sponsors by combining deep scientific expertise, medical leadership,

Interactive Brokers Adds Brazilian Futures through Brazil’s B3 Exchange5.8.2026 16:00:00 CEST | Press release

Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced that eligible clients outside of Brazil can now trade Brazilian futures in addition to equities through the B3 exchange. Interactive Brokers was the first broker to provide international investors with streamlined, low-cost access to B3. Offering Brazilian futures and equities alongside products across more than 170 markets worldwide underscores IBKR’s commitment to broadening global market access and giving clients efficient, cost-effective ways to diversify through a single, unified platform. Access to B3 provides exposure to one of Latin America’s most active and liquid markets, providing long-term growth potential across multiple sectors and another way for investors to pursue emerging market opportunities. "Global investors deserve seamless, low-cost access to the world's most compelling markets, including emerging economies shaping tomorrow's financial landscape," said Milan Galik, Chief Executive Off

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye